TPTicketplus Ltd.

🇺🇸 US
7.31
USD
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
4/9
Neutral
Operating cash flow data missing (C3, C4)
Graham ?
$2.4
Pahalı
Lothien Robustness Summary
77/100
Lothien Sağlamlık: Çok Güçlü (77/100)
Temel göstergelerin büyük çoğunluğu pozitif. Kârlılık, büyüme ve değerleme açısından güçlü görünüm. | Kısa Vade: Olumlu | Uzun Vade: Olumlu | Pozitif: 8 | Negatif: 1 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte $2M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+405.2 arttı ($420,761 → $2M). Kısa vadede olumlu momentum.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+116.5 arttı. Büyüme trendi sağlıklı.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+68.2 arttı ($7M → $13M). Talep güçlü.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+80.8 arttı. Şirket büyüyor.
Yüksek Net Kâr Marjı
Net kâr marjı %16.9. Her 100$ satıştan 17$ kâr kalıyor.
Orta Seviye Borç
Net borç/özkaynak 1.43x. Yönetilebilir seviyede ama takip edilmeli.
Yüksek PD/DD
PD/DD: 9.95. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek ROE
Özkaynak getirisi (ROE): %33.9. Sermaye verimli kullanılıyor.
Özkaynak Büyümesi
Özkaynak çeyreklik %+66.2 arttı. Şirket içsel birikimle güçleniyor.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-51.4 düşebilir. Sonraki bilançoya dikkat.

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Valuation
Potential?
-
Balance Sheet Analysis? Q2026/9
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 7.31 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %16.9
Net profit margin %16.9 — at healthy level. Compared to previous quarter +11.2 point increase.
ROE - Return on Equity (TTM) %33.9
ROE %33.9 — high return on equity.
EBITDA Margin %27.4
EBITDA margin %27.4 — operationally very efficient.
Gross Profit Margin %46.3
Gross profit per revenue %46.3. Strong pricing power.
Free Cash Flow Margin (TTM) %-15.2
TTM Free Cash Flow is %-15.2'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 23.6x Sector: 58.5x
F/K 23.6x — sector median's (58.5x) %60 below. Attractive for value investing.
P/B Ratio 9.95x Sector: 3.59x
PD/DD 9.95x — sector median's %177 above. Expensive book value.
EV/EBITDA 9.5x Sector: 22.9x
EV/EBITDA 9.5x — sector median's (22.9x) %59 below. Cheap relative to EBITDA.
Indebtedness
Current Ratio 1.10x
Current ratio 1.10x — borderline, attention required.
Net Debt / EBITDA 1.5x
Net Debt/EBITDA 1.5x — manageable debt level.
Debt / Equity 1.84x
Debt/Equity 1.84x — high leverage. Sensitive to debt cycle changes.
Interest Coverage 8.6x
Interest coverage 8.6x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+80.8
Revenue YoY %80.8 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+116.5
Net profit YoY %116.5 increased (2026/6) — extraordinary profit growth.
Seasonality Analysis Q2 (Nis-Haz)
Historically strongest quarter: Q2 (Apr-Jun) (avg. profit 1.1M). Weakest quarter: Q4 (Oct-Dec) (avg. profit 326.7K).
Score Explanations
Lothien Robustness
-
Good robustness (69/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Potential
-
Plus %36.4 expected value (9.97) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %72.
Components: PE target: 18.32 | P/B target: 2.92 | EV/EBITDA target: 17.63 | DCF target: 1.83
Damodaran Valuation
-
Low Damodaran score (40/100). DCF analysis does not support current price.
Weak
Dalio Risk Analysis
-
Moderate debt risk (68/100). Interest coverage ratio 8.6x — strong. Debt/EBITDA 1.5x — in healthy range.
Leverage: 68/100 | Debt Service: 78/100 | Quality: 84/100
ROIC - Return on Capital
%20.6
ROIC (%20.6) cost of capital 6.4 bps above → company creates value.
WACC: %14.2
DCF Discounted Cash Flow
1.13
DCF (1.13) current price %84.5 below — cash flows do not support current price.
Current price: 7.31
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Operating cash flow data missing (C3, C4)
Neutral
Graham Intrinsic Value
$2.4
Expensive
⚖️ Sector Comparison
P/E Ratio
23.6x vs 58.5x
Sector median's %60 below — cheap
P/B Ratio
9.95x vs 3.59x
Compared to sector %177 more expensive (by book value)
EV/EBITDA
9.5x vs 22.9x
Compared to sector %59 lower EV/EBITDA
ROIC vs WACC
%20.6 vs %14.2 WACC
ROIC 6.4 bps above cost of capital
Net Profit Margin (TTM)
%11.4 vs %32.6 EBITDA margin
TTM net profit margin %11.4
↔
TRAMA-99 Trend — Near TRAMA
Price (7.31), TRAMA-99 line (7.31) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 7.31
TRAMA: 7.31
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

TP — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.